14-44505105-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032135.4(FSCB):āc.1883A>Cā(p.Glu628Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000289 in 1,421,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FSCB | NM_032135.4 | c.1883A>C | p.Glu628Ala | missense_variant | 1/1 | ENST00000340446.5 | NP_115511.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FSCB | ENST00000340446.5 | c.1883A>C | p.Glu628Ala | missense_variant | 1/1 | 6 | NM_032135.4 | ENSP00000344579.4 |
Frequencies
GnomAD3 genomes AF: 0.0000810 AC: 12AN: 148146Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000202 AC: 3AN: 148568Hom.: 0 AF XY: 0.0000244 AC XY: 2AN XY: 81928
GnomAD4 exome AF: 0.0000228 AC: 29AN: 1272934Hom.: 0 Cov.: 25 AF XY: 0.0000240 AC XY: 15AN XY: 626250
GnomAD4 genome AF: 0.0000810 AC: 12AN: 148146Hom.: 0 Cov.: 29 AF XY: 0.0000833 AC XY: 6AN XY: 72046
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 23, 2023 | The c.1883A>C (p.E628A) alteration is located in exon 1 (coding exon 1) of the FSCB gene. This alteration results from a A to C substitution at nucleotide position 1883, causing the glutamic acid (E) at amino acid position 628 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at